American Regent, Inc. Moves Corporate Office to Melville, NY

News provided by

Mar 05, 2020, 10:00 ET

MELVILLE, N.Y., March 5, 2020 /PRNewswire/ -- American Regent, Inc., a manufacturer and distributor of pharmaceuticals that addresses diverse medical and veterinary needs, announced today that it has moved its corporate offices to Melville, New York. The relocation is a consolidation of corporate functions, which had previously been spread across several buildings in eastern Suffolk County, to office space more centrally located on Long Island. For more than 50 years, American Regent has set a high standard for responsiveness and reliability as a U.S.-based manufacturing company. The company applies innovative thinking to respond to customer needs by developing and delivering complex, hard-to-manufacture injectable medicines.

"American Regent's growth over the past several years has enabled us to bring important medicines to patients, and has required us to re-evaluate our business needs," says Ken Keller, President and CEO of American Regent. "I am very excited about this next chapter for our company, and the synergies, collaboration, and engagement this new office space will bring. A primary focus of the management team is to continue investing in our employees. It is because of them that we have been increasingly successful in product development, obtaining FDA approvals, and ensuring our products are known and available to healthcare professionals and the patients who need them."

American Regent also continues to invest in the manufacturing side of its business, with expansion in its Ohio and Long Island, New York facilities to provide state-of-the-art U.S. manufacturing. "Our manufacturing expansion, coupled with this corporate office move," adds Keller, "positions American Regent to be more nimble in an increasingly competitive pharmaceutical industry. Speed, agility, and investing in our people and capabilities will be key as we continue building for our future."

About American Regent, Inc.
American Regent, Inc., a member of the Daiichi Sankyo Group, is a Long Island, New York-based pharmaceutical company. American Regent develops, manufactures, and supplies high-quality sterile injectable medicines.

Supporting patient health is the guiding principle of American Regent. Its promise is to provide the healthcare marketplace with a steady supply and broad portfolio of branded and generic specialty injectable medications for people as well as animals. American Regent is a top-10 U.S. injectable pharmaceuticals supplier with products in various therapeutic areas including IV additives, anti-inflammatories, diuretics, cytotoxics, and diagnostic dyes. Additionally, for nearly 20 years, American Regent has been a leader in IV iron therapy, and supplies two of the top-selling brands in the U.S. today. For more information, please visit www.americanregent.com.

SOURCE American Regent, Inc.